Methamphetamines (Meth)

What does it look like?
Methamphetamine is a crystal-like powdered substance that sometimes comes in large rock-like chunks. When the powder flakes off the rock, the shards look like glass, which is another nickname for meth. Meth is usually white or slightly yellow, depending on the purity.

How is it used?
Methamphetamine can be taken orally, injected, snorted, or smoked.

What are its short-term effects?
Immediately after smoking or injection, the user experiences an intense sensation, called a "rush" or "flash," that lasts only a few minutes and is described as extremely pleasurable. Snorting or swallowing meth produces euphoria - a high, but not a rush. After the initial "rush," there is typically a state of high agitation that in some individuals can lead to violent behavior. Other possible immediate effects include increased wakefulness and insomnia, decreased appetite, irritability/aggression, anxiety, nervousness, convulsions and heart attack.

What are its long-term effects?
Methamphetamine is addictive, and users can develop a tolerance quickly, needing larger amounts to get high. In some cases, users forego food and sleep and take more meth every few hours for days, 'binging' until they run out of the drug or become too disorganized to continue. Chronic use can cause paranoia, hallucinations, repetitive behavior (such as compulsively cleaning, grooming or disassembling and assembling objects), and delusions of parasites or insects crawling under the skin. Users can obsessively scratch their skin to get rid of these imagined insects. Long-term use, high dosages, or both can bring on full-blown toxic psychosis (often exhibited as violent, aggressive behavior). This violent, aggressive behavior is usually coupled with extreme paranoia. Methamphetamine use can also cause strokes and death.

What is its federal classification?
Schedule II
Source
National Institute on Drug Abuse (NIDA); Drug Enforcement Administration (DEA)

NIDA InfoFacts: Treatment Approaches for Drug Addiction

NIDA InfoFacts: Treatment Approaches for Drug Addiction

Drug addiction is a complex but treatable disease. It is characterized by compulsive drug craving, seeking, and use that persist even in the face of severe adverse consequences. For many people, drug abuse becomes chronic, with relapses possible even after long periods of abstinence. In fact, relapse to drug abuse occurs at rates similar to those for other well-characterized, chronic medical illnesses such as diabetes, hypertension, and asthma. As a chronic, recurring illness, addiction may require repeated episodes of treatment before sustained abstinence is achieved. Through treatment tailored to individual needs, people with drug addiction can recover and lead productive lives.

The ultimate goal of drug addiction treatment is to enable an individual to achieve lasting abstinence, but the immediate goals are to reduce drug abuse, improve the patient's ability to function, and minimize the medical and social complications of drug abuse and addiction. Like people with diabetes or heart disease, people in treatment for drug addiction will also need to change their behavior to adopt a more healthful lifestyle.

In 2006, 23.6 million persons aged 12 or older needed treatment for an illicit drug or alcohol use problem (9.6 percent of the persons aged 12 or older). Of these, 2.5 million (10.8 percent of those who needed treatment) received treatment at a specialty facility. Thus, 21.2 million persons (8.6 percent of the population aged 12 or older) needed treatment for an illicit drug or alcohol use problem but did not receive it. These estimates are similar to the estimates for 2005.*

Untreated substance abuse and addiction add significant costs to families and communities, including those related to violence and property crimes, prison expenses, court and criminal costs, emergency room visits, healthcare utilization, child abuse and neglect, lost child support, foster care and welfare costs, reduced productivity, and unemployment.
The cost to society of illicit drug abuse alone is $181 billion annually.1 When combined with alcohol and tobacco costs, they exceed $500 billion including healthcare, criminal justice, and lost productivity.2,3 Successful drug abuse treatment can help reduce these costs in addition to crime, and the spread of HIV/AIDS, hepatitis, and other infectious diseases. It is estimated that for every dollar spent on addiction treatment programs, there is a $4 to $7 reduction in the cost of drug-related crimes. With some outpatient programs, total savings can exceed costs by a ratio of 12:1.

1 Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States: 1992–2002. Washington, DC: Executive Office of the President (Publication No. 207303), 2004.2 Harwood, H. Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data Report. Prepared by the Lewin Group for the National Institute on Alcohol Abuse and Alcoholism, 2000. 3 Centers for Disease Control and Prevention. Annual Smoking–Attributable Mortality, Years of Potential Life Lost, and Productivity Losses — United States, 1997–2001. Morbidity and Mortality Weekly Report 54(25):625–628, July 1, 2005.4 The National Treatment Improvement Evaluation Study (NTIES): Highlights. DHHS Publication No. (SMA) 97-3159. Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Office of Evaluation, Scientific Analysis and Synthesis,

The Relationship of Chronic Viral Hepatitis, Alcoholism, and Cirrhosis to Liver Caner

The Relationship of Chronic Viral Hepatitis, Alcoholism, and Cirrhosis to Liver Cancer

Medical Author: Jay W. Marks, MD

Medical Editor: Leslie J. Schoenfield, MD,

Cancer can start within the liver (primary liver cancer or hepatocellular cancer) or spread to the liver (metastatic liver cancer) from other sites, such as the colon. Cancer that starts in the liver, which I will refer to simply as liver cancer, is the fifth most common cancer in the world. In the U.S., it is among the 10 most common cancers. This cancer is more frequent among Native Americans, Asians, Pacific Islanders, and Hispanics than among Caucasians.
Liver cancer is a bad cancer. It has frequently spread beyond the liver by the time it is discovered, and only 5% of patients with liver cancer that has begun to cause symptoms survive even five years without treatment. The only hope for patients who are at risk for liver cancer is regular surveillance so that the cancers can be found early. Early cancers can be treated by surgical removal (resection), destruction of the individual tumors, or liver transplantation. Although the current techniques for surveillance are not very good at detecting early liver cancer, newer techniques are being tested and appear to be better.
The most common diseases associated with liver cancer are chronic viral hepatitis, alcoholism, and cirrhosis (scarring of the liver). Moreover, chronic viral hepatitis is common in alcoholism, and both viral hepatitis and alcoholism cause cirrhosis which usually precedes the development of cancer. Therefore, the contributions and interrelationships of alcohol abuse, viral hepatitis, and cirrhosis in the development of liver cancer are complex. Despite the complexity, it is important to try to understand the contributions of each disease so that patients at highest risk for liver cancer can be targeted for surveillance. Theoretically, they also might be targeted with treatments that prevent the development of liver cancer, when such treatments are developed.
Learn more about the link between alcoholism and liver cancer »

Drug, alcohol treatment vital in solving problem

Drug, alcohol treatment vital in solving problem
Health Happenings
Alamogordo Daily NewsBy Ken Nicholson, For the Daily News
Posted: 08/09/2009 12:00:00 AM

In spite of the nationwide prohibition of street drugs, New Mexico and Otero County, as well as the rest of the United States, has a persistently growing drug problem with increasing numbers of younger students using drugs and alcohol.
With that is the typically disastrous results of addiction, incarceration, unintended pregnancies, failing grades and school drop-outs. While education and law enforcement are making strides in stopping the illegal drug trade while educating our youth about the consequences of drug use, drug and alcohol use continues to be a devastating problem, suggesting once again that peer-pressure can be a stronger force than education.

Making drugs illegal has, no doubt, been a deterrent to the vast majority of Americans. On the other hand, this has put the burden of the drug war on law enforcement and the judicial system, especially since 1986 when Congress enacted mandatory minimum sentencing laws, which mandated judges to deliver fixed sentences to individuals convicted of the crime of addiction, regardless of culpability or other mitigating circumstances.

Overwhelmingly, drug defendants 85 percent of them are nonviolent, according to Families Against Mandatory Minimums. Yet many mostly minorities and the poor are convicted of felonies and receive mandatory minimum sentences of five to 10 years or more. Also, those addicted at the time of their incarceration are generally still addicted upon release and still need treatment.

While giving a big boost to the private prison industry, incarcerating drug offenders is expensive for the tax payer. In New Mexico, the average cost of incarceration is $30,000 per inmate per year. The average cost of probation and parole in New Mexico is $1,533 per person per year. According to a 1998 study conducted at the Brown University Center for Alcohol and Addiction Studies, the average cost for drug treatment per year is between $1,800 for regular outpatient care and $6,800 for long-term residential care.

For each person that receives treatment, rather than being incarcerated, New Mexico could save between $22,000 and $27,000 per year (prison savings less probation/parole and treatment costs), according to the Drug Policy Alliance.
The American Medical Association has given formal recognition to the disease concept regarding addiction since 1956. Medically, addiction is classified as a chronic disease similar to other chronic diseases such as Type II diabetes, hypertension, asthma and cardiovascular disease. Research conducted by the National Institute on Drug Abuse has shown that they all have similar relapse rates.

Addiction is a chronic, relapsing brain disorder that should be managed with all the tools at medicine's disposal. While lifestyle choices may be a contributing factor in diabetes, lung cancer or cardiac disease and is the only factor in an addict's first use. No one regards lifestyle choice as a reason to withhold treatment for any of these conditions, except for addiction.
Just as it takes an average of seven attempts for a smoker to quit tobacco, we should understand that relapse is an integral part of the disease of any addiction. We should treat the addict with the same care and compassion we treat diabetes or cardiac patients struggling to make prescribed lifestyle changes.

Ken Nicholson represents Peace & Justice, of La Luz. This column is provided as a service of the Otero County Community Health Council and the Alamogordo Daily News as a way to provide the latest in health and wellness information, services and events. This column is submitted by OCCHC partners and does not necessarily reflect the views or policies of the OCCHC.